We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$51.4B
AUM Growth
+$1.46B
Cap. Flow
+$987M
Cap. Flow %
1.92%
Top 10 Hldgs %
18.85%
Holding
2,686
New
375
Increased
1,038
Reduced
898
Closed
357

Top Buys

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$512M
2
AMD icon
Advanced Micro Devices
AMD
+$401M
3
RBLX icon
Roblox
RBLX
+$384M
4
TSM icon
TSMC
TSM
+$371M
5
TJX icon
TJX Companies
TJX
+$271M

Sector Composition

Rank Sector Weight
1 Technology 27.47%
2 Consumer Discretionary 14.55%
3 Financials 14.39%
4 Healthcare 12.45%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA icon
2226
Ginkgo Bioworks
DNA
$495M
$98.5K ﹤0.01%
11,856
-19,252
-62% -$207K
SMWB icon
2227
Similarweb
SMWB
$557M
$97.4K ﹤0.01%
13,000
-11,800
-48% -$95.1K
TG icon
2228
Tredegar Corp
TG
$270M
$96.9K ﹤0.01%
13,500
-12,700
-48% -$96.3K
TH icon
2229
Target Hospitality
TH
$1.61B
$96.9K ﹤0.01%
+12,100
New +$91.8K
CDXS icon
2230
Codexis
CDXS
$137M
$96.8K ﹤0.01%
59,400
+31,900
+116% +$65.1K
SLN
2231
Silence Therapeutics
SLN
$527M
$96.7K ﹤0.01%
15,900
-26,700
-63% -$171K
VYNE icon
2232
VYNE Therapeutics
VYNE
$17.2M
$94.6K ﹤0.01%
163,100
+106,500
+188% +$42.7K
ADAM
2233
Adamas Trust
ADAM
$781M
$94.5K ﹤0.01%
12,951
-83,850
-87% -$595K
XOS icon
2234
Xos
XOS
$27.7M
$92.5K ﹤0.01%
51,100
-5,500
-10% -$13.5K
FBIO icon
2235
Fortress Biotech
FBIO
$111M
$92.4K ﹤0.01%
+25,250
New +$72K
GSM icon
2236
FerroAtlántica
GSM
$632M
$91.4K ﹤0.01%
19,700
+1,900
+11% +$8.77K
VTGN icon
2237
VistaGen Therapeutics
VTGN
$9.07M
$91.2K ﹤0.01%
137,732
-19,300
-12% -$69.7K
QNCX icon
2238
Quince Therapeutics
QNCX
$17.8M
$90.8K ﹤0.01%
+136
New +$68.4K
KRRO icon
2239
Korro Bio
KRRO
$163M
$90K ﹤0.01%
11,237
-172
-2% -$4.02K
HIMX
2240
Himax Technologies
HIMX
$2.24B
$89.3K ﹤0.01%
10,900
-149,300
-93% -$1.26M
SNDL icon
2241
Sundial Growers
SNDL
$331M
$88.6K ﹤0.01%
53,400
+700
+1% +$1.41K
CRSR icon
2242
Corsair Gaming
CRSR
$1.08B
$88.5K ﹤0.01%
14,900
+3,200
+27% +$22.3K
RPAY icon
2243
Repay Holdings
RPAY
$314M
$88K ﹤0.01%
24,100
-7,800
-24% -$31.3K
MRCC
2244
DELISTED
Monroe Capital Corp
MRCC
$87.9K ﹤0.01%
13,800
-28,200
-67% -$187K
NAGE
2245
Niagen Bioscience
NAGE
$253M
$87.8K ﹤0.01%
+13,800
New +$96K
JELD icon
2246
JELD-WEN Holding
JELD
$97.4M
$85.9K ﹤0.01%
34,900
-102,700
-75% -$337K
INAB icon
2247
IN8bio
INAB
$11.6M
$85.1K ﹤0.01%
36,351
-9,400
-21% -$17.9K
RFIL icon
2248
RF Industries
RFIL
$139M
$82.7K ﹤0.01%
+14,300
New +$99K
SFL icon
2249
SFL Corp
SFL
$1.59B
$82K ﹤0.01%
+10,500
New +$80.6K
ASM
2250
Avino Silver & Gold Mines
ASM
$996M
$82K ﹤0.01%
+13,200
New +$71K

Similar funds

Two Sigma Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, Two Sigma Advisers held 2,686 positions worth $51.4B, up 2.9% from $50B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Two Sigma Advisers's Q4 2025 filing shows 375 new, 1,038 increased, 898 reduced and 357 closed positions. Its largest new stake was Kimberly-Clark: 2,442,100 shares worth $246M. The largest sale was Bank of America, an estimated $569M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Two Sigma Advisers's largest Q4 2025 buy was Kimberly-Clark: 2,442,100 shares worth $246M.
  • Two Sigma Advisers added most to ServiceNow in Q4 2025, an estimated $512M increase.
  • Two Sigma Advisers's biggest Q4 2025 reduction was Bank of America, cutting an estimated $569M.
  • Two Sigma Advisers fully exited Nebius Group N.V. in Q4 2025, selling an estimated $257M.
  • Two Sigma Advisers's ten largest holdings make up 19% of its $51.4B portfolio in Q4 2025.
  • Two Sigma Advisers opened 375 new positions and closed 357 in Q4 2025.
  • Two Sigma Advisers's portfolio value rose 2.9% quarter-over-quarter to $51.4B.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.